Comparison of immediate therapeutic effects of 3% diquafosol and 2% rebamipide in dry eye disease: a prospective, randomized, paired-eye trial

Myung-Sun Song, Eunyoung Kim, Nayoon Park, Youngsub Eom, Jong Suk Song, Dong Hyun Kim · 2026

Read Comparison of immediate therapeutic effects of 3% diquafosol and 2% rebamipide in dry eye disease: a prospective, randomized, paired-eye trial by Myung-Sun Song, Eunyoung Kim, Nayoon Park, Youngsub Eom, Jong Suk Song, Dong Hyun Kim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13381911.txt.

Description

Myung-Sun Song and co-authors compare two eye drops for dry eye disease in a paired-eye trial, in work published in 2026. Both drugs are known to help signs and symptoms, but their immediate effects had never been compared head to head. Thirty patients received one drug in one eye and the other drug in the fellow eye.

Thirty minutes after the drops, both eyes improved on symptom scores and tear film stability. Symptom relief was greater with diquafosol than with rebamipide, while tear stability gains were alike. Both drugs raised levels of a key tear mucin, MUC5AC, by similar amounts, and a second mucin stayed unchanged. Other measures, such as tear volume and corneal sensitivity, were tracked too. The authors judge the two drugs broadly equal for early benefit.

Catalog record

CREATORMyung-Sun Song, Eunyoung Kim, Nayoon Park, Youngsub Eom, Jong Suk Song, Dong Hyun Kim
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13381911

Browse the full library · About the Tower of Babel